Otolaryngology experts examined important clinical questions in five areas—from antivirals for newborn hearing to tonsillar cancer—during the Triological Society’s “Best Practices” session.
![](https://www.enttoday.org/wp-content/uploads/2021/03/ENT_0321_pg21a.png)
Otolaryngology experts examined important clinical questions in five areas—from antivirals for newborn hearing to tonsillar cancer—during the Triological Society’s “Best Practices” session.
New but limited data have emerged suggesting that oral steroids with olfactory training may be a safe and effective treatment for loss of smell due to COVID-19.
The presence of parosmia is associated with clinically relevant recovery in olfactory discrimination and identification function in patients with post-infectious olfactory dysfunction who are receiving olfactory training.
Here’s why the inclusion of oral corticosteroids as part of appropriate medical therapy for chronic rhinosinusitis may be the lower-risk strategy.
Although acupuncture is used to treat a variety of medical conditions, there is insufficient evidence to support its use in chronic rhinosinusitis.
In patients with suspected CRS based on symptoms but with normal endoscopic findings, an upfront CT scan is a viable option prior to initiating empiric medical therapy.
Routine postoperative adjunct treatments in patients with idiopathic CSF are unnecessary and may expose them to adverse long-term side effects.
Rhinovirus, coronavirus, parainfluenza virus, and Epstein-Barr virus are associated with postviral olfactory dysfunction onset (PVOD), and may cause olfactory dysfunction.
What is the lowest effective dose of abobotulinum toxin A injection for allergic rhinitis?
A look at how the new disposable nasopharyngolaryngoscope (NPL) compare in quality and cost to the reusable NPL.